by NDNR-emmabelle-2026. | Sep 2, 2026 | September 2026: Oncology
Share This ArticleThe pan-RAS(ON) inhibitor daraxonrasib represents an emerging advance in metastatic pancreatic ductal adenocarcinoma. This review examines its mechanism, clinical evidence, adverse effects, and implications for evidence-informed supportive care and...
by NDNR-emmabelle-2026. | Sep 2, 2026 | September 2026: Oncology
Share This ArticleA case of stage IV HER2-positive invasive ductal carcinoma explores the use of a ketogenic, very-low-carbohydrate diet alongside conventional cancer therapy, highlighting the potential roles of metabolic health, nutrition, and lifestyle in...
by NDNR-emmabelle-2026. | Sep 1, 2026 | September 2026: Oncology
Share This ArticleFrom organizing medical records and preparing questions to bringing a support person and seeking second opinions, this practical guide helps cancer patients and survivors become informed, confident participants in their care. In my forty years of...
by NDNR-emmabelle-2026. | Sep 1, 2026 | September 2026: Oncology
Share This ArticleThis case report describes the use of a botanical immunomodulatory regimen incorporating beta-glucan, Maitake D-fraction, and antioxidant support in a 73-year-old patient with a progressively enlarging intraductal pancreatic mucinous neoplasm who...
by NDNR-emmabelle-2026. | Sep 1, 2026 | September 2026: Oncology
Share This ArticleA case of high-grade serous ovarian carcinoma demonstrates how serial liquid biopsy can track treatment response and progression, clarify ambiguous molecular findings, and provide a shared objective measure across naturopathic and conventional...
